Physician profile
Victoria Wright
NPI 1336727304
$993.96
in general payments reported to CMS, 2019-2025
18 companies · $920 in 2025
The $920 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $74.46 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $180.00 | 2025 | Ozempic, Rybelsus |
| Amgen INC. | $173.49 | 2025 | Evenity, Repatha, Otezla |
| Sanofi-Aventis U.S. LLC | $163.04 | 2025 | |
| Glaxosmithkline, LLC. | $69.13 | 2024-2025 | Arexvy, Shingrix |
| Exact Sciences Corporation | $57.55 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $57.51 | 2025 | |
| Lilly USA, LLC | $41.01 | 2025 | Zepbound, Kisunla |
| Abbvie INC. | $38.13 | 2025 | |
| Axsome Therapeutics, INC. | $27.50 | 2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.80 | 2025 | Jardiance |
| Merck Sharp & Dohme LLC | $24.28 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Eisai INC. | $23.91 | 2025 | |
| Bavarian Nordic A/S | $23.75 | 2025 | Vivotif |
| Bausch Health US, LLC | $22.41 | 2025 | Aplenzin, Wellbutrin |
| Novartis Pharmaceuticals Corporation | $20.47 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $17.79 | 2025 | Opsumit, Uptravi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.06 | 2025 | Xifaxan |
| Cequr Corporation | $14.13 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.